FDA NDC Directory · JSON-LD · Markdown

OXCARBAZEPINE

NDC 60505-4130 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA213369
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsOXCARBAZEPINE (600 mg/1)
Marketing started20240903
Package count2

External sources

Source: openFDA. Public-domain (CC0).